BSX
BOSTON SCIENTIFIC CORP
Healthcare • CIK 0000885725
Loading...
Market Cap
$61.85B
P/E (TTM)
17.2x
Rev Growth (TTM)
+13.5%
Net Margin (TTM)
17.5%
FCF Yield (TTM)
5.7%
FCF Margin (TTM)
17.3%
Filings
Primary-source SEC disclosures, read end-to-end — every figure traceable to its filing.
10-Q2026 Q22026-08-03source
8-KEarnings2026-07-29source
8-KJul 20262026-07-27source
8-KMay 20262026-05-18source
8-KMay 20262026-05-18source
What your agent reads
Investor Relations
Company-published material — management’s own words, not SEC-audited. Each source below is labeled so your agent knows what to verify.
Company-published, not SEC-audited
Earnings
Q2 2026
19 days ago
8-K releaseRevenue
$5.44B
+7.5%
Net Income
$907.00M
+13.8%
EPS
N/A
—
Most recent quarterly earnings snapshot
Cash Flow Health
Free Cash Flow8/8 positive
TTM$3.6B
Q2 '26
$1.3B+648%
Q1 '26
$171M-83%
FCF Margin
TTM17.3%
Q2 '2623.5%+615%
Sector: 0.0%Top 10%
OCF Margin21.6%
OCF/NI1.23x
CapEx Coverage5.0x
FCF Yield5.7%
FCF Growth (2Y)+34%
Cash Conversion Cycle
110 days
DSO: –+DIO: 174−DPO: 63
Cash flow trends & capital efficiency
Capital Allocation
Total Shareholder Yield
TTM0.0%
Div Yield0.0%
+Buybacknot disclosed
Dividend & Payout Metrics
Dividend Yield (TTM)0.0%
Free Cash Flow (TTM)$3.6B
Capital Return / FCF0.0%
Est. Dividends Paid (TTM)$0
Buyback data not disclosed in this company's filings.
Shows how management rewards shareholders
Valuation Metrics
Price-to-EarningsTTM
17.2x
Volatile
8Q: 51.2x-4616%
Valuation Lenses
Earnings
17.2x
vs – sector
Cash Flow
36.6x
EV/FCF vs –
Growth-Adj
0.4xPEG
Undervalued for growth
Quality-Adj
1.6P/E per %ROIC
ROIC: 11.0%
Shareholder Returns
Dividend
–
Buyback
–
Total Yield
–
Market Cap$61.85B
EV$73.94B
Multi-angle valuation analysis with sector context
Margins & Efficiency
ROIC 75th pctile
Profitability Cascade
Gross
69.9%
Operating
19.8%
Top 25% in sector
Net
17.5%
Margins Unknown
Return on Invested CapitalTTM
11.0%
Stable
+0.0% YoY+5.0%
P25MedianP75
75th pctl (med: -0.0%)
DuPont BreakdownROIC = Margin × Turn × (1+D/E)
NOPAT Margin
18.8%
8Q: 15.7%
Asset Turnover
0.48x
8Q: 0.48x
Leverage (1+D/E)
1.51x
D/E: 0.51x
DuPont: 13.7% ≈ 11.0% ROIC
Asset & CapEx Efficiency
Fixed Asset Turn
5.35x
8Q:5.58x
-47.9%
Invested Cap Turn
0.64x
8Q:0.64x
Flat
CapEx Intensity
2.8%
8Q:2.5%
CapEx/Depreciation
0.64x
FCF vs Net Margin Gap-0.2 pts
Margin trends, ROIC, and capital efficiency
Balance Sheet & Solvency
D/E 0.51x
Net Debt / EBITDA
–Net Debt: $12.09B
Interest Coverage
–
Leverage Metrics
Debt-to-Equity
0.51x
Balance sheet risk & solvency analysis
Related Research
2 related posts